Arrowstreet Capital’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.2M Buy
519,201
+88,534
+21% +$6.51M 0.02% 564
2025
Q4
$29.2M Buy
430,667
+28,064
+7% +$1.75M 0.02% 634
2025
Q3
$23M Buy
402,603
+330,526
+459% +$19.6M 0.01% 683
2025
Q2
$3.99M Buy
+72,077
New +$3.38M ﹤0.01% 1245
2024
Q2
Sell
-33,058
Closed -$1.14M 1567
2024
Q1
$1.14M Buy
+33,058
New +$1.06M ﹤0.01% 1297

Other funds holding DBD

Arrowstreet Capital's DBD Position: Q1 2026 in Review

Arrowstreet Capital increased its Diebold Nixdorf (DBD) stake by 21% in Q1 2026, buying an estimated $6.51M and bringing the position to 519,201 shares worth $39.2M. The position accounts for 0.02% of the portfolio, ranked #564.

Arrowstreet Capital first reported a position in DBD in Q1 2024 and has held it in 5 quarters since. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • Arrowstreet Capital held 519,201 shares of Diebold Nixdorf worth $39.2M as of Q1 2026.
  • Arrowstreet Capital bought 88,534 Diebold Nixdorf shares in Q1 2026, an estimated $6.51M.
  • Diebold Nixdorf made up 0.02% of Arrowstreet Capital's portfolio in Q1 2026, its #564 holding.
  • Arrowstreet Capital first reported a position in Diebold Nixdorf in Q1 2024 and has held it in 5 quarters since.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.